WipeCOPD is an acronym for Web-based Interactive Professional Education in Chronic Obstructive Pulmonary Disease. This program was developed with the help of an educational grant entitled the “GlaxoSmithKline Distinguished Scholar Award in Respiratory Health” from the Chest Foundation, the philanthropic arm of the American College of Chest Physicians.
A group of 5 multidisciplinary faculty (Sandra Adams, Edward Diamond, Nicola Hanania, JoEllen Wynne, and Barbara Yawn), under the guidance of education specialists from the American College of Chest Physicians, originally developed content for an interactive, one-day “live” course on COPD entitled “COPD: What Really Works: A Best Practices Workshop in Primary Care”. This “live” course was presented by three clinicians and two respiratory therapists in 21 cities across the US throughout 2009-2010 and reached just over 370 healthcare professional learners. Because these “live” courses are very labor intensive and costly and because busy healthcare professional learners often do not have a full day to devote to education, Dr. Adams and Dr. Casey Jones modified the content from the original “live” courses into short videos covering specific aspects of COPD care that can be viewed on the internet by healthcare professionals with as little as 5-10 minutes of free time. These high-quality videos are interactive and have been developed to represent clinically relevant topics in the diagnosis, assessment, and management of COPD.
Based on the initial reviews and feedback from WipeCOPD, Dr. Adams has created a not-for-profit entity entitled WipeDiseases Foundation, which will provide support for future web-based interactive educational offerings. Recently, she received another educational grant for patient safety from the University of Texas System, which is allowing Dr. Adams and her colleagues to develop WipeAsthma (Web-based, Interactive Professional Education in Asthma). In the future, we plan to expand the educational offering to other conditions and to develop WipeVTE (venous thromboembolism) and WipePH (pulmonary hypertension).
Our overarching goal is to provide healthcare professionals with the tools to actually change their clinical practice and improve outcomes of our patients with COPD, asthma, and other diseases as well.